Cancer signaling pathway could illuminate new avenue to therapy

(University of Wisconsin-Madison) Researchers from the University of Wisconsin School of Medicine and Public Health and Carbone Cancer Center have better defined a pro-growth signaling pathway common to many cancers that, when blocked, kills cancer cells but leaves healthy cells comparatively unharmed. The study, published Nov. 21 in the journal Nature Cell Biology, could establish new avenues of therapeutic treatments for many types of solid tumors.